The OPPI Delhi Declaration on NCDs was unveiled and OPPI KPMG Report on healthcare access initiatives was released during the summit
The Organisation of Pharmaceutical Producers of India (OPPI) hosted its Fifth Healthcare Access Summit in Mumbai. The summit was supported by the Ministry of Health and Family Welfare, and the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers. The theme of the summit was ACT (Awareness, Capacity building and Treatment) on Non-Communicable Diseases (NCDs); discussions centred on addressing the fast-growing risk of NCDs and measures to contain this disease burden.
The summit brought together government officials, policy-makers, leaders from the healthcare and pharmaceutical industries, global healthcare experts and other distinguished professionals. Participants discussed diverse aspects of tackling the NCD challenges and potential solutions, at a day-long event.
Lars Rebien Sørensen, President and Chief Executive Officer Executive, Novo Nordisk said “Diabetes is a global challenge. Through this summit, we are looking forward to engaging with all the stakeholders in the fight against diabetes. As an industry, we should collaborate with likeminded stakeholders in order to identify the best interventions, the most optimal healthcare responses and to ensure people with diabetes have access to the right treatment at the right time in the right way.”
Speaking at the summit, cricketing hero, Sachin Tendulkar, Changing Diabetes Brand Ambassador, Novo Nordisk said, “The diabetes pandemic is a cause for concern in India and around the world. It is an enormous public health challenge that calls for countries of the world to unite together with polices aimed at curbing the disease. Changing Diabetes movement in India pioneered by Novo Nordisk has been instrumental in creating awareness about the disease and timely intervention. Let’s control it before it controls us.”
Dr Shailesh Ayyangar, President, OPPI, and Managing Director, India & Vice President, Sanofi India said, “Indeed, we have many challenges in our country, but many healthcare indices look much better today, as compared with 50 years ago. We have successfully won the battles against leprosy and polio. However, NCDs are emerging as a grave public health concern. Our members have been working closely with the Government in the herculean task of enhancing awareness about NCDs and engaging in patient support programmes to for better patient outcomes.”
The ‘KPMG-OPPI’ report on healthcare access initiatives’ was released at the summit. The report presents the current healthcare scenario in India. It also summarises various interventions undertaken by OPPI member companies towards improving patient access to healthcare.
Kanchana TK, Director General, OPPI said, “Our healthcare system should be patient-centric. An integrated patient-oriented approach, combined with a universal chronic disease management framework is imperative. We need to act now on NCDs. Restructuring and strengthening healthcare systems have resulted in a decline in the incidence of infectious disease. This provides adequate evidence that the same result is possible for NCDs. Our members fully support Government’s endeavour and initiatives in containing this disease burden, and look forward to working with them to accomplish India’s NCD reduction goals set for 2025.”
The Delhi Declaration on Non-Communicable Diseases was announced by renowned endocrinologist Dr Shanshank Joshi at the Summit. The Declaration articulates the intention of reducing the burden of NCDs though innovative and sustainable solutions that decrease the social, economic and medical burden of NCDs.
At the summit, OPPI also recognised Aravind Eye Care Systems with the OPPI Healthcare Access Award 2016; The Cancer Institute (WIA), Adyar, Chennai, with the OPPI Healthcare Access Award on NCDs and Dr V Mohan, Dr Mohan’s Diabetes Specialties Centre with the OPPI Award for Improving Access to Diabetes Care.
EH News Bureau
- Advertisement -
Comments are closed.